Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Special https://ift.tt/3nX8fwP
https://ift.tt/eA8V8J
Friday, October 16, 2020
Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO Latest
Subscribe to:
Post Comments (Atom)
Popular Posts
-
https://ift.tt/eA8V8J South African playwright and novelist Damon Galgut on Wednesday won the 2021 Booker Prize for "The Promise"...
-
In the last few months, everything has changed. The life we knew has taken an unimaginable turn. Now most people stay at home and watch the ... -
Scientists have known for several months that the new coronavirus can be suspended in droplets ejected by patients when they speak and breat... -
US President Donald Trump during a press briefing said the United States may provide a vaccine for the novel coronavirus to other countries... -
The modern biotech firm COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the monkeys'... -
Neymar scored the winning goal when Paris Saint-Germain defeated 10-man Saint-Etienne 1-0 in the French Cup final on Friday, the country... -
China aims to launch a rover to Mars on Thursday on a journey that coincides with a similar US mission as the powers take their rivalry to d... -
India recorded 40,425 new cases of coronavirus and 681 deaths in the past 24 hours, the biggest jump in a single day, government data showed... -
3D Animation, CGI animation, VFX designing What is 3D Animation ? It is the method of generating three-dimensional transfer photos in a digi... -
Barack Obama is signaling a willingness to sharply critique his successor, President Donald Trump, and fill what many Democrats see as a nat...
No comments:
Post a Comment